A phase I study of daily everolimus plus low-dose weekly cisplatin for patients with advanced solid tumors

被引：0
|
作者：
Matthew G. Fury
Eric Sherman
Sofia Haque
Susan Korte
Donna Lisa
Ronglai Shen
Nian Wu
David Pfister
机构：
[1] Memorial Sloan-Kettering Cancer Center,Department of Medicine, Head and Neck Medical Oncology Service
[2] Memorial Sloan-Kettering Cancer Center,Department of Radiology
[3] Memorial Sloan-Kettering Cancer Center,Department of Epidemiology and Biostatistics
[4] Memorial Sloan-Kettering Cancer Center,Deparment of Pharmacology
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Everolimus; Cisplatin; Phase I; Solid tumor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：591 / 598
页数：7
相关论文
共 50 条
  • [21] Phase I and pharmacokinetic study of low-dose, three-times daily oral etoposide in patients with refractory solid tumors
    Schwartsmann, G
    Di Leone, L
    Caldas, APF
    Campos, O
    Viegas, MAV
    Cancela, AI
    Sander, E
    Ferreira, F
    Schunemann, H
    Mans, DRA
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 1481 - 1482
  • [22] Phase I and pharmacokinetic study of low-dose, three-times daily oral etoposide in patients with refractory solid tumors
    Schwartsmann, G
    Di Leone, L
    Caldas, APF
    Campos, O
    Cancela, AI
    Viegas, MAV
    Mans, DRA
    ANNALS OF ONCOLOGY, 1998, 9 : 138 - 138
  • [23] A phase I dose escalation and pharmacodynamic study of weekly administered AlbuleukinTM in patients with advanced solid tumors.
    Agarwala, SS
    Bukowski, RM
    Kirkwood, J
    Weiss, P
    Olencki, T
    Grzegorewski, KJ
    Melder, R
    Fox, RA
    Herpst, JM
    Gallant, G
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6230S - 6231S
  • [24] Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors
    Fornier, M. N.
    Rathkopf, D.
    Shah, M.
    Patil, S.
    O'Reilly, E.
    Tse, A. N.
    Hudis, C.
    Lefkowitz, R.
    Kelsen, D. P.
    Schwartz, G. K.
    CLINICAL CANCER RESEARCH, 2007, 13 (19) : 5841 - 5846
  • [25] Clofarabine administered weekly to adult patients with advanced solid tumors in a phase I dose-finding study
    Cunningham, CC
    Nemunaitis, J
    Senzer, N
    Vukelja, S
    Weiss, J
    Ferrier, A
    Vukovic, V
    Weitman, S
    Richards, D
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 223S - 223S
  • [26] Phase I and pharmacokinetic trial of weekly oral fluorouracil given with eniluracil and low-dose leucovorin to patients with solid tumors
    Grem, JL
    Harold, N
    Shapiro, J
    Bi, DQ
    Quinn, MG
    Zentko, S
    Keith, B
    Hamilton, JM
    Monahan, BP
    Donavan, S
    Grollman, F
    Morrison, G
    Takimoto, CH
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) : 3952 - 3963
  • [27] Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
    Pronk, LC
    Schellens, JHM
    Planting, AST
    vandenBent, MJ
    Hilkens, PHE
    vanderBurg, MEL
    deBoerDennert, M
    Ma, J
    Blanc, C
    Harteveld, M
    Bruno, R
    Stoter, G
    Verweij, J
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1071 - 1079
  • [28] Phase I Study of Weekly Cisplatin, Bolus Fluorouracil and Escalating Doses of Irinotecan in Advanced Solid Tumors
    Ku, Geoffrey Y.
    O'Reilly, Eileen M.
    Saltz, Leonard B.
    Schrag, Deborah
    Maki, Robert G.
    Kelsen, David P.
    Ilson, David H.
    CANCER INVESTIGATION, 2009, 27 (04) : 402 - 406
  • [29] PHASE I STUDY OF THE PHARMACOKINETICS AND TOLERABILITY OF EVEROLIMUS IN CHINESE PATIENTS WITH ADVANCED SOLID TUMORS
    Xu, B.
    Shen, L.
    Ye, D.
    Jappe, A.
    Cherfi, A.
    Wang, H.
    Yuan, R.
    Wu, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 178 - 178
  • [30] Phase I trial of daily imatinib mesylate and weekly paclitaxel in patients with advanced refractory solid tumors
    Bahrani, A
    Hwang, J
    Malik, S
    Marshall, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 216S - 216S
12345